君实生物 · Junshi Biosciences

Science

Clinical Trials Overview

Explore selected publicly registered studies sponsored by Shanghai Junshi Bioscience Co., Ltd. Each listing links to the sponsor’s study record on ClinicalTrials.gov.

Recruitment status reflects the date of the registry update. Individual study sites may have different availability.

Find a Trial

Clinical Trial Listings

NCT07876557Recruiting

JS212 in recurrent or metastatic triple-negative breast cancer

JS212Phase IIRegistry updated 5 November 2026

View registry record
NCT07808827Recruiting

JS203 plus chemotherapy in relapsed or refractory diffuse large B-cell lymphoma

JS203Phase IIIRegistry updated 14 October 2026

View registry record
NCT06095583Recruiting

Toripalimab alone or with tifcemalimab after chemoradiotherapy in limited-stage small-cell lung cancer

Toripalimab / TifcemalimabPhase IIIRegistry updated 27 July 2026

View registry record
NCT06888830Recruiting

JS212 in advanced malignant solid tumors

JS212Phase I/IIRegistry updated 8 July 2026

View registry record
NCT07081022Active, not recruiting

JS203 combination regimens in B-cell non-Hodgkin lymphoma

JS203Phase IIRegistry updated 4 September 2026

View registry record
NCT03581786Completed

JUPITER-02 · Toripalimab with chemotherapy in recurrent or metastatic nasopharyngeal carcinoma

ToripalimabPhase IIIRegistry updated 2 September 2025

View registry record